FDA Inspection 995189 — New York Blood Center Inc

New York Blood Center Inc — FEI 3005255747

The FDA completed an inspection of New York Blood Center Inc on December 5, 2016 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 5, 2016
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)